CVS Health Corp. Q2 2026 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2026, and the six months ended on that date. CVS Health operates as an integrated health solutions company with four reportable segments: Health Care Benefits (Aetna), Health Services (CVS Caremark), Pharmacy & Consumer Wellness (Retail), and Corporate/Other. As of June 30, 2026, the company operated approximately 9,000 retail locations and served approximately 87 million PBM plan members and 37 million health insurance members.
Key Financial Metrics
| Metric (in millions) | Q2 2026 | Q2 2025 | 6M 2026 | 6M 2025 |
|---|---|---|---|---|
| Total Revenues | $106,096 | $98,915 | $206,522 | $193,503 |
| Operating Income | $4,703 | $2,381 | $9,383 | $5,755 |
| Net Income (Attributable to CVS) | $2,979 | $1,021 | $5,922 | $2,800 |
| Diluted EPS | $2.31 | $0.80 | $4.61 | $2.21 |
| Operating Cash Flow (6M) | $10,594 (2026) vs $6,453 (2025) | |||
| Cash & Equivalents (Balance Sheet) | $11,329 (June 30, 2026) | |||
| Long-Term Debt | $59,452 (June 30, 2026) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 7.3% in Q2 and 6.7% in the first six months of 2026 compared to the prior year, driven by growth across all segments.
- Profitability Surge: Operating income increased 97.5% in Q2 and 63.0% for the six-month period. This significant improvement is primarily attributed to the absence of $833 million in legacy litigation charges and $288 million in losses on Accountable Care assets that were recorded in the prior year.
- Segment Performance:
- Health Care Benefits: Adjusted operating income rose 85.5% in Q2, driven by improved Government business performance and the absence of prior-year premium deficiency reserves.
- Health Services: Revenues grew 11.5% in Q2 due to pharmacy drug mix and brand inflation, partially offset by client price improvements.
- Pharmacy & Consumer Wellness: Operating income increased 91.7% in Q2, aided by the absence of legacy litigation charges and contributions from Rite Aid asset acquisitions.
- Cost Management: Operating expenses decreased 1.5% in Q2 and 1.1% for the six months, largely due to the lack of prior-year litigation and restructuring charges.
Outlook, Risks, and Contingencies
- Regulatory Environment: The company faces ongoing investigations and litigation regarding PBM practices, including a proposed settlement with the FTC announced in July 2026 to resolve outstanding investigations. Legislation regulating PBM activities is active in many states.
- Legal Contingencies:
- Opioid Litigation: As of June 30, 2026, the remaining accrual for opioid-related litigation matters was approximately $3.4 billion.
- Omnicare Litigation: A liability of $165 million remains on the balance sheet related to joint and several liability for penalties in a False Claims Act case involving Omnicare, pending bankruptcy court approval of a settlement.
- Capital Allocation: The company did not repurchase any shares during the six months ended June 30, 2026. The quarterly dividend remained at $0.665 per share. Approximately $11.5 billion remains available under authorized share repurchase programs.
- Trends: Management notes elevated utilization levels in Q2 2026 and continued pressure from pharmaceutical manufacturers regarding rebate calculations. The company expects these trends to persist.
Investor Verification Checklist
- Quality of Earnings: Verify the extent to which the reported profit growth is driven by the absence of one-time litigation charges ($833M in Q2 2025) versus organic operational improvements.
- Legal Exposure: Monitor the status of the $3.4 billion opioid litigation accrual and the finalization of the FTC settlement and Omnicare bankruptcy proceedings.
- Regulatory Impact: Assess the potential financial impact of state and federal PBM regulations and the outcome of the FTC settlement on future pricing models.
- Membership Trends: Review the decline in Commercial medical membership (down 19.7% in Q2) versus growth in Government membership to understand the shifting risk profile of the Health Care Benefits segment.
- Cash Flow Sustainability: Confirm that the 64.2% increase in operating cash flow is sustainable given the timing of payments and receipts noted by management.